Clinical Trial

Exergaming-based Sitting Tai Chi for Sarcopenia and/or Frailty

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This randomized controlled trial will evaluate the effects of an exergaming-based sitting Tai Chi program on muscle strength, physical function, cognition, and psychosocial outcomes in older adults living in residential care facilities who are at risk of sarcopenia and/or prefrailty. Eligible participants aged 60 years or older will be identified using simple screening criteria for sarcopenia and prefrailty and will not meet full diagnostic criteria for sarcopenia or frailty. A total of 152 participants will be randomly assigned to either an individually supervised exergaming-based sitting Tai Chi intervention or a group-based general health education control, each delivered twice weekly for 12 weeks. The primary outcome is dominant-hand grip strength, a core indicator of sarcopenia-related muscle weakness. Key secondary outcomes include sitting balance and functional reach assessed by the Modified Functional Reach Test, with additional secondary measures of muscle mass, lower-extremity function, activities of daily living, reaction time and health-related quality of life. Outcomes will be assessed at baseline, mid-intervention, post-intervention, and 3-month follow-up. The findings will provide preliminary evidence on whether chair-based exergaming Tai Chi can be integrated into routine residential care to support healthy aging and functional independence.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-06-05
notable Primary completion pushed: 2027-08-31 -> 2027-09-30 2026-06-05
Trial Details
NCT Number NCT07616219
Lead Sponsor Hong Kong Metropolitan University
Conditions Sarcopenia in Elderly, Frailty at Older Adults
Enrollment 152 participants
Start Date 2026-03-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01